Use of a pharmaceutical formulation comprising trimagnesium dicitrate salt or trimagnesium dicitrate, to treat pathological calcifications including arteriosclerosis, where the compounds are present in hydrate or anhydrate form

摘要

Use of a pharmaceutical formulation (I) comprising trimagnesium dicitrate salt or trimagnesium dicitrate as an active agent, to treat pathological calcifications including arteriosclerosis, is claimed, where the compounds: in the formulation can exist alone or in combination and are present in hydrate or anhydrate form. ACTIVITY : Antiarteriosclerotic. MECHANISM OF ACTION : None given.